The Vernalis Design Platfor integrates fragment-based approaches, structural biology, biophysics, assay technology and molecular modelling with extensive synthetic organic and medicinal chemistry expertise to enable drug discovery on both established and novel targets.

Vernalis has collaborations across many therapeutic areas with global partners, and a heritage of successful internal drug discovery in oncology and anti-infectives.